SCHEMBL194091

SCHEMBL194091

C=COc1ccc(C)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.48
RELA Q04206 1/20 0.43
TDP1 Q9NUW8 2/20 0.42
CYP3A4 P08684 1/20 0.41
TSHR P16473 1/20 0.41
TEAD4 Q15561 1/20 0.41
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
ALDH1A1 P00352 1/20 0.39
POLB P06746 1/20 0.39
MAPT P10636 1/20 0.39
LMNA P02545 1/20 0.39
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
KCNH2 Q12809 1/20 0.36
HPGD P15428 1/20 0.35
HTT P42858 1/20 0.35
CYP2A6 P11509 1/20 0.35
DRD2 P14416 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL473606 0.86 CHRNB2 (0.34) CYP3A4TSHRALDH1A1MAPTLMNA
SCHEMBL15447941 0.85 TSHR (0.41) ACHERELATDP1CYP3A4TSHR
SCHEMBL20090502 0.82 TSHR (0.34) ACHERELACYP3A4TSHRTEAD4
SCHEMBL6071105 0.80 ACHE (0.44) ACHERELATDP1CYP3A4TSHR
SCHEMBL274124 0.79 CA1 (0.58) ACHERELATDP1CYP3A4TSHR
SCHEMBL8302497 0.78 HTT (0.49) TDP1TEAD4MEN1KMT2AALDH1A1
SCHEMBL11965976 0.78 ESR2 (0.33) CYP3A4TSHRALDH1A1MAPTLMNA
SCHEMBL28462523 0.78 ACHE (0.52) ACHERELATDP1CYP3A4TSHR
SCHEMBL21881722 0.78 ACHE (0.52) ACHERELATDP1CYP3A4TSHR
SCHEMBL14289128 0.78 ALDH1A1 (0.44) TDP1CYP3A4TSHRTEAD4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1473 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114057962-B Polymer double-chain/inorganic nano particle asymmetric compound and preparation method thereof 清华大学 2023-05-05 CN claimed
CN-114057961-B Polymer double-chain/inorganic nanoparticle composite Janus material and preparation method thereof 清华大学 2022-11-18 CN claimed
CN-114057946-B Polymer double-chain/polymer nanoparticle composite Janus material and preparation method thereof 清华大学 2022-11-11 CN claimed
CN-113583372-B Preparation method and application of single molecular chain nano-particles 中国科学院化学研究所 2022-04-01 CN claimed
CN-114057961-A Polymer double-chain/inorganic nanoparticle composite Janus material and preparation method thereof 清华大学 2022-02-18 CN claimed
CN-114057946-A Polymer double-chain/polymer nanoparticle composite Janus material and preparation method thereof 清华大学 2022-02-18 CN claimed
CN-114057962-A Polymer double-chain/inorganic nano-particle asymmetric compound and preparation method thereof 清华大学 2022-02-18 CN claimed
CN-113583372-A Preparation method and application of single molecular chain nano-particles 中国科学院化学研究所 2021-11-02 CN claimed
CN-111826022-A UV (ultraviolet) photocuring high-corrosion-resistance and high-sensitivity liquid photosensitive ink and preparation method thereof 张家港科思创感光新材料有限公司 2020-10-27 CN claimed
US-7060771-B2 Transparent fluorine-containing copolymer CENTRAL GLASS COMPANY, LIMITED (JP) 2006-06-13 US claimed
EP-4743828-A1 PHOTOCURABLE AS WELL AS THERMALLY CURABLE COMPOSITIONS SUITABLE FOR LOW TEMPERATURE CURING BASF SE (DE) 2026-05-20 EP disclosed
EP-4565378-B1 METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA SICPA HOLDING SA (CH) 2026-05-06 EP disclosed
US-12616995-B2 Methods for producing overt security features exhibiting one or more indicia SICPA HOLDING SA (CH) 2026-05-05 US disclosed
EP-4722199-A1 AZOLE COMPOUND, METHOD FOR SYNTHESIZING SAID AZOLE COMPOUND, AND USE THEREOF SHIKOKU CHEMICALS CORPORATION (JP) 2026-04-08 EP disclosed
US-12570858-B2 Curable composition, cured product, cured film, display panel, and method for producing cured film TOKYO OHKA KOGYO CO., LTD. (JP) 2026-03-10 US disclosed
US-3948960-A ADDITION, HYDROGEN PEROXIDE, INTRAPHASE PONY INDUSTRIES, INC., A CORP. OF DE 1976-04-06 US disclosed
US-3938992-A Electrographic developing composition and process using a fusible, crosslinked binder polymer EASTMAN KODAK COMPANY (US) 1976-02-17 US disclosed
US-3936429-A Reactive polymer FUJI PHOTO FILM CO., LTD. (JA) 1976-02-03 US disclosed
US-3932573-A Process for producing glass fiber reinforced injection molding compounds ETHYL CORPORATION (US) 1976-01-13 US disclosed
US-3931248-A Reactive high polymer compound FUJI PHOTO FILM CO., LTD. (JA) 1976-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12570858-B2 Curable composition, cured product, cured film, display panel, and method for producing cured film C5, CFL1, C9 ACHE 2386/4885RELA 3168/4885TDP1 3078/4885
US-12616995-B2 Methods for producing overt security features exhibiting one or more indicia ATG4B, TPM4, ATG4A ACHE 3209/4885RELA 3344/4885TDP1 2099/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.